TWD 19.35
(-1.02%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 65.65 Million TWD | -17.24% |
2022 | 79.33 Million TWD | 221.67% |
2021 | 24.66 Million TWD | -13.51% |
2020 | 28.51 Million TWD | -7.23% |
2019 | 30.73 Million TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 46.06 Million TWD | 0.0% |
2024 Q2 | 46.06 Million TWD | 0.0% |
2023 Q1 | 76.86 Million TWD | -3.11% |
2023 Q3 | 65.65 Million TWD | -14.59% |
2023 FY | 65.65 Million TWD | -17.24% |
2023 Q4 | 65.65 Million TWD | 0.0% |
2023 Q2 | 76.86 Million TWD | 0.0% |
2022 Q3 | 79.33 Million TWD | 0.0% |
2022 FY | 79.33 Million TWD | 221.67% |
2022 Q4 | 79.33 Million TWD | 0.0% |
2021 FY | 24.66 Million TWD | -13.51% |
2020 FY | 28.51 Million TWD | -7.23% |
2019 FY | - TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Allied Biotech Corporation | 72.02 Million TWD | 8.843% |
GeneFerm Biotechnology Co., Ltd. | 76.14 Million TWD | 13.781% |
Easywell Biomedicals, Inc. | 330.44 Million TWD | 80.132% |
TTY Biopharm Company Limited | 403.04 Million TWD | 83.71% |
Synmosa Biopharma Corporation | 1.45 Billion TWD | 95.499% |
Orient EuroPharma Co., Ltd. | 2.2 Billion TWD | 97.02% |
Center Laboratories, Inc. | 4.42 Billion TWD | 98.518% |
Tien Liang BioTech Co., Ltd. | 377 Thousand TWD | -17315.119% |
Orient Pharma Co., Ltd. | 323.73 Million TWD | 79.719% |
InnoPharmax Inc. | 5.38 Million TWD | -1118.994% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 100.83 Million TWD | 34.886% |
Excelsior Biopharma Inc. | 300.25 Million TWD | 78.133% |
DV Biomed Co., Ltd. | 315.74 Million TWD | 79.207% |
Foresee Pharmaceuticals Co., Ltd. | 13.11 Million TWD | -400.61% |
Handa Pharmaceuticals, Inc. | 7.67 Million TWD | -755.886% |
UniPharma Co., Ltd. | - TWD | -Infinity% |
Anxo Pharmaceutical Co., Ltd. | 499.69 Million TWD | 86.861% |
Alar Pharmaceuticals Inc. | 138 Thousand TWD | -47476.087% |
Winston Medical Supply Co., Ltd. | 56.05 Million TWD | -17.122% |
Mercury Biopharmaceutical Corporation | 41.66 Million TWD | -57.567% |
TSH Biopharm Corporation Limited | - TWD | -Infinity% |